Pembrolizumab in children and young adults with classical hodgkin lymphoma (chl) with slow early response (ser) to front-line chemotherapy (keynote-667)

PEDIATRIC BLOOD & CANCER(2023)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要